Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$55.36
pos +0.12
+0.22%
Today's Range: 54.78 - 55.31 | BMY Avg Daily Volume: 12,588,800
Last Update: 12/08/16 - 11:15 AM EST
Volume: 2,278,837
YTD Performance: -19.70%
Open: $54.91
Previous Close: $55.24
52 Week Range: $49.03 - $77.12
Oustanding Shares: 1,671,229,946
Market Cap: 93,639,013,874
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 5
Moderate Buy 1 1 0 0
Hold 8 9 10 10
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.47 2.50 2.56 2.65
Latest Dividend: 0.38
Latest Dividend Yield: 2.71%
Dividend Ex-Date: 10/05/16
Price Earnings Ratio: 18.19
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
18.19 33.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.35% -19.76% 9.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.30 -0.10 -0.02
Net Income -19.60 -0.30 -0.13
EPS -22.50 -0.20 -0.07
Earnings for BMY:
EBITDA 2.27B
Revenue 16.56B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $0.66 $0.76 $2.87 $2.96
Number of Analysts 9 3 12 12
High Estimate $0.70 $0.78 $2.95 $3.09
Low Estimate $0.59 $0.74 $2.80 $2.74
Prior Year $0.38 $0.74 $2.01 $2.87
Growth Rate (Year over Year) 74.27% 2.25% 42.54% 3.23%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

updateCiti Healthcare Conf.

Dec 7, 2016 | 7:18 AM EST
Thomson ONE
Citi Global Healthcare Conference (Day 1 of 2) - 12/07/16 - 12/08/16 New York, NY
RMPIA
By

Doug Kass

 | Dec 1, 2016 | 5:48 PM EST
The U.S. dollar weakened. The price of crude oil rallied for a second day in a row, rising $1.50 to almost $51. Gold flat, no bounce. Agricultural commodities: Wheat up $0.07, corn down $0.05, soybean unchanged, oats up $0.05. Lumber up $1. Bonds got schmeissed but traded well off the day's lows (as the 10-year yield touched 2.5%). The 10-year and long-bond yields rose by 9 basis points. The 2s/10s spread rose by another 5 basis points to 130 basis points. Muncipals were lower. Junk bonds got hit badly, despite the rise in crude oil. Blackstone / GSO Strategic Credit Fund (BGB)  rose $0.08. Banks were powerful to the upside. I reshorted at reasonably good prices in the afternoon, after covering my small rental shorts in pre-market trading earlier. Insurance stocks flew. Long Hartford Financial (HIG)  , which rose. Brokerages so strong -- Morgan Stanley (MS) and Goldman Sachs (GS) (up $7). Retail was strong led by Target (TGT) , Foot Locker (FL) , Nike (NKE) and JC Penney (JCP) (long). Autos were the "world's fair." I still have tag end short positions. I expect the upside move to get over-done short term, and I will reload on the short side. Energy stocks up, but small relative to the commodity. Old tech was clobbered. International Business Machines (IBM) , Intel (INTC) , Cisco (CSCO) (short and working nicely) and Microsoft (MSFT) got bashed along with the entire sector. Biotech was down 2%. Allergan (AGN) and Gilead Sciences (GILD) were weak. New lows Vertex Pharmaceuticals (VRX) . Spec weak again (Portula Pharmaceuticals (PTLA) , Sage (SAGE) , Intrexon (XON) , FibroGen (FGEN) , ACADIA Pharmaceuticals (ACAD)  . Big pharma hurtin' badly, once more. Merck (MRK) , Bristol-Myers Squibb (BMY) and Eli Lilly (LLY) being liquidated, much like tech. Media mixed message. Disney (DIS) lower. Ag equipment: Deere (DE) up large on an upgrade, though Caterpillar (CAT) still experiencing weak fundies. Consumer staples broadly lower. Campbell Soup (CPB) excelled on a relative basis, though. (T)FANG a source of funds. Tesla (TSLA) , Facebook (FB) , Amazon (AMZN) and Alphabet (GOOGL) a collective mess. In individual stocks: DuPont (DD) , new high. Radian (RDN) up another up 2%. Oaktree Capital (OAK) not so mighty. Apple hit. Here are some value-added contributions on the site today: 1. Jim "El Capitan" Cramer on " Not What Bulls Wanted to See ."  2. "Meet" Brett Jensen on rotation.  3. Tim "Not Judy or Phil" Collins
By

Bruce Kamich

 | Nov 29, 2016 | 11:31 AM EST
The stock will eventually rebase, but we don't know where or when.
RMPIA
By

Doug Kass

 | Nov 28, 2016 | 3:28 PM EST
The U.S. dollar weakened. Crude oil rose by $1.23 to $47.29 on conflicting OPEC reports. Gold climbed by about $12 per ounce to above $1,190 (it had been up $18 earlier). Agricultural commodities were mixed: Wheat down $0.02, corn flat, soybean up $0.12 (continuing its monster run in price) and oats down $0.06. Lumber up $3. Bonds were lower in yield and higher in price. The 10-year yield dropped by five basis points and the long bond by three basis points. The 2s/10s spread declined by three basis points as the yield curve flattened. Municipals flat-lined. Closed-end muni-bond funds recovered a bit. Junk bonds slightly higher. Blackstone/GSO Strategic Credit Fun (BGB) was flat. Banks got clipped. But brokerages were slightly higher. Insurance profit-taking after a big run. Retail was on sale with Nordstrom (JWN) , Home Depot (HD) , Best Buy (BBY) , Target (TGT) and JC Penney (JCP) weak. Autos lower. According to J.D. Power, incentives are at near-record levels. Not good for profits/margins. Biotech down 1.5% (Celgene (CELG) and Gilead Sciences (GILD) off a beaner each), but spec biotech (e.g. Intrexon (XON) , Portola Pharmaceuticals (PTLA)  , SAGE (SAGE)  , Aerie Pharmaceuticals (AERI) ) weak. Big pharma continues to weaken, led by Merck (MRK)  , Bristol-Myers Squibb (BMY)  , Eli Lilly (LLY)
RMPIA
By

Doug Kass

 | Nov 22, 2016 | 3:02 PM EST
The market remains resistant. Brokerages and banks hang in strongly. The Russell Index is killing the shorts -- up ($0.75), again. Retail is experiencing another leg to the upside. JC Penney (JCP) , Home Depot (HD) , Lowe's (LOW) , Best Buy (BBY) , Target (TGT
By

Real Money

 | Nov 22, 2016 | 1:49 PM EST
Interpreting "K-M curves" correctly is an important tool for biotech investors.
RMPIA
By

Jim Cramer

 | Nov 21, 2016 | 4:15 PM EST
Today high-growth tech and natural resources stocks are both going higher without sending much lower at all.
RMPIA
By

Guy Ortmann

 | Nov 14, 2016 | 12:27 PM EST
What stocks have changed direction in the past week.

updateCredit Suisse Healthcare Conf.

Nov 8, 2016 | 7:12 AM EST
Thomson ONE
Credit Suisse Healthcare Conference
RMPIA
By

Doug Kass

 | Nov 7, 2016 | 4:55 PM EST
The U.S. dollar strengthened meaningfully. Any more strength will begin to raise concerns about multinational profits. The price of crude oil expanded by $0.80 to nearly $45/barrel. But, we are still in a short term downtrend. Gold fell be $23. I rebuilt my GLD position on the weakness. We are near the 200 day moving average. Ag commodities: wheat down $0.04, corn down $0.02, soybeans up $0.08 and oats are flat. Fertilizer stocks traded well today. Lumber up $1. Bonds got schmeissed. iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down a beaner. The 10-year U.S. note yield rose by four basis points and the long bond by three basis points. The 2s/10s spread widened by two basis points to 101 basis points. Municipals were surprisingly weaker. Closed end muni bond funds flatlined. But high yield was much stronger iShares iBoxx $ High Yid Corp Bond ETF (HYG) +$1 and SPDR Barclays Capital High Yield Bnd ETF (JNK) +$0.40. Blackstone/GSO Strategic Credit Fund (BGB) +$0.13. Banks benefited from the steepening yield curve. I shorted JPMorgan Chase (JPM) , Citigroup (C) and Financial Select Sector SPDR Fund (XLF) late in the day. Insurance stocks were terrific. Long Hartford Financial (HIG) (large) looks like it might be breaking out. (I still owe you guys an analysis of the good quarter release from last week -- coming soon! Small shorts in Lincoln National (LNC) and Metlife (MET) , rose. Brokerages Morgan Stanley (MS) and Goldman Sachs (GS) were the "world's fair." Autos advanced. I remain short (small) General Motors (GM) and Ford (F) . Retail rebounded. My only long JC Penney (JCP) was punk (up a dime after being up three times that amount earlier in the day). Biotech was +3.5%. Allergan (AGN) , Celgene (CELG) ++ Speculative biotech (Portola Pharmaceuticals (PTLA)  , SAGE Therapeutics (SAGE) , Aerie Pharmaceuticals (AERI) ,  Nektar Therapeutics (NKTR
we'll roll DIS here and bank a win in COST SOLD DIS JAN 100 CALL A...
The great Skip Raschke joins me after the close to talk options, trading and other stuff h...
Big day for TWTR.  The stock is up over 6% with the help of a nice bump in volume.&nb...
Shares of Weyerhaeuser (WY) are breaking above five month horizontal resistance and makin...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.